|
Donanemab slows cognitive decline in trials
|
|
Resverlogix Corp.
|
Mar 21, 2021 03:12AM
|
|
Any relation or possible future collab?
|
|
Resverlogix Corp.
|
Mar 19, 2021 12:00AM
|
|
Choline and ApoE4
|
|
Resverlogix Corp.
|
Mar 16, 2021 12:51PM
|
|
Re: Pharmacological Modulation of BET Family in Sepsis
|
3
|
Resverlogix Corp.
|
Mar 11, 2021 10:32PM
|
|
Pharmacological Modulation of BET Family in Sepsis
|
7
|
Resverlogix Corp.
|
Mar 11, 2021 02:27AM
|
|
Don't See Us Listed but thought it might interest some
|
2
|
Resverlogix Corp.
|
Mar 09, 2021 11:23PM
|
|
Another variation
|
13
|
Resverlogix Corp.
|
Mar 04, 2021 12:52AM
|
|
Australia Associated Press
|
14
|
Resverlogix Corp.
|
Mar 03, 2021 01:57PM
|
|
Re: Fabry competition
|
4
|
Resverlogix Corp.
|
Feb 27, 2021 11:51PM
|
|
Fabry competition
|
4
|
Resverlogix Corp.
|
Feb 27, 2021 11:45PM
|
|
Re heart & covid. May be repeat but note Nichols comment
|
4
|
Resverlogix Corp.
|
Feb 27, 2021 11:41PM
|
|
Emergent expansion of clinical epigenetics in CVD
|
10
|
Resverlogix Corp.
|
Feb 27, 2021 11:35PM
|
|
Apabetalone may reduce chemotherapy resistance in ovarian cancer
|
6
|
Resverlogix Corp.
|
Feb 27, 2021 11:29PM
|
|
Re: Tablet vs Capsule
|
1
|
Resverlogix Corp.
|
Feb 22, 2021 03:00AM
|
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
1
|
Resverlogix Corp.
|
Feb 13, 2021 06:00PM
|
|
Tablet vs Capsule
|
2
|
Resverlogix Corp.
|
Feb 13, 2021 05:38PM
|
|
Re: Our own BKC on the webcast
|
3
|
Resverlogix Corp.
|
Feb 13, 2021 04:55PM
|
|
Re: Our own BKC on the webcast
|
|
Resverlogix Corp.
|
Feb 13, 2021 04:17PM
|
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
|
Resverlogix Corp.
|
Feb 13, 2021 04:01PM
|
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
|
Resverlogix Corp.
|
Feb 13, 2021 03:51PM
|
